- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Invivo acquisition gets on track
The waiting is over for Intermagnetics. The time set aside under the Hart-Scott Rodino Antitrust Improvements Act of 1976 has expired without any requests for additional information regarding the company's proposed acquisition of Invivo, a manufacturer
The waiting is over for Intermagnetics. The time set aside under the Hart-Scott Rodino Antitrust Improvements Act of 1976 has expired without any requests for additional information regarding the company's proposed acquisition of Invivo, a manufacturer of patient monitoring devices, including ones compatible with MR. The two companies are now able to proceed with the acquisition.
Invivo signed a definitive purchase agreement in mid-December for an all-cash transaction under which Intermagnetics will acquire all of Invivo's outstanding stock for $22 per share.
Intermagnetics' proposed expansion is coming in the context of improving financial results. The company announced last month that second-quarter net income rose about 21% to $4.4 million. Second-quarter net sales increased to $39.9 million from $36.7 million on increased sales and profits in its instrumentation sector, as well as a return to normalized sales and continued gains from its MRI product lines.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
